Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study

This publication has 22 references indexed in Scilit:

• Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study
  Journal of Cancer Research and Clinical Oncology, 2024
• Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
  Annals of Oncology, 2023
• Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
  International Journal of Clinical Oncology, 2022
• One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry
  Thrombosis Research, 2022
• First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study
  Journal of Cancer Research and Clinical Oncology, 2022
• Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study
  Cancer Medicine, 2021
• Direct Oral Anticoagulants in Patients With Active Cancer
  JACC: Cardiooncology, 2020
• Trousseau's syndrome triggered by an immune checkpoint blockade in a non‐small cell lung cancer patient
  European Journal of Immunology, 2018
• Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases
  European Journal of Cancer, 2013
• Prognosis of Cancers Associated with Venous Thromboembolism
  New England Journal of Medicine, 2000